The Building Empowerment and Resilience Therapeutic Program for Women With a History of Trauma
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Change in Coping Self-Efficacy Scale (CSES)
研究概览
简要总结
The current study aims to test a novel therapeutic intervention for women who have a history of interpersonal trauma. The Building Empowerment and Resilience (BEAR) Therapeutic group incorporates psychological skills, psychoeducation, and physical empowerment training, all within a therapeutic process. It will be implemented iwith women who have experienced interpersonal trauma (physical, sexual, or emotional abuse/neglect). The investigators aim to understand how this program effects one's self-efficacy and whether the program can reduce rates mental health problems (such as depression and anxiety) and reduce the rates of revictimization. Women who participate in the BEAR group must be able to attend in-person sessions. The control group can be remote.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women ages 18-70
- •History of physical, sexual, and/or emotional abuse/neglect/violence, with subsequent interpersonal or psychological distress (e.g., depression or anxiety) related to this history.
排除标准
- •Active, significant substance abuse
- •Significant medical conditions that would preclude safe participation in the study
- •High levels of depression with significant suicide risk
- •Psychiatric instability
- •History of assaultive behavior or is judged to be at potential risk to assault others.
结局指标
主要结局
Change in Coping Self-Efficacy Scale (CSES)
时间窗: baseline to post-group (3 months)
The CSES is designed to measure an individual's perception of her competence to carry out coping strategies effectively when faced with a challenge or threat.
Trauma Symptom Inventory-II (TSI-2).
时间窗: baseline to post-group (3 months)
The TSI-2 is a self-report measure of trauma-related symptoms and behaviors.
次要结局
未报告次要终点
研究者
Jennifer Keller
Clinical Professor
Stanford University